Literature DB >> 2050323

Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases.

S Bresson-Hadni1, A Franza, J P Miguet, D A Vuitton, D Lenys, E Monnet, G Landecy, G Paintaud, P Rohmer, M C Becker.   

Abstract

Between 1986 and 1989, orthotopic liver transplantations were performed in our unit for 17 patients with incurable alveolar echinococcosis. Ten patients had hilar involvement (group I), and seven patients had posterior localization (five of them had chronic Budd-Chiari syndrome) (group II). The delay between diagnosis and the orthotopic liver transplantation was more than 48 mo in group Ia (six patients), less than 24 mo in group Ib (four patients) and less than 48 mo in group II. Previous operations were more common in group Ia than in group Ib and II. Five patients have died-four in group I and one in group II. The actuarial survival rate at 15 mo was 75%. Early reoperations were frequent (69%), mainly caused by rebleeding. Bacterial and fungal infections occurred only in group Ia (four cases) and group II (three cases). In eight patients (palliative group), residual foci of infected nonhepatic tissue occurred after surgery. The titer of specific antibodies decreased during the first 3 mo in all the patients but one. In patients with radical liver transplantation, the complete disappearance of specific antibodies occurred within 2 yr in four cases. In the remaining five patients, specific antibodies remained detectable, but no evidence of recurrence has been obtained up to now. In the palliative group, a peak of specific IgM occurred at 3 mo; an increase of specific IgG was observed later. The growth of residual parasitic foci was relatively slow, and all these patients remained asymptomatic with a mean follow-up of 19 mo. We conclude that orthotopic liver transplantation is feasible in incurable alveolar echinococcosis and could be proposed without delay to patients with parasitic Budd-Chiari syndrome or complicated secondary biliary cirrhosis. In the other cases, the best time to perform an orthotopic liver transplantation is more difficult to determine. Nevertheless, in the perspective of an orthotopic liver transplantation, the management of these patients has to change, and repetitive laparotomies for palliative surgical procedures have to be replaced by interventional radiology.

Entities:  

Mesh:

Year:  1991        PMID: 2050323

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  [Alveolar echinococcosis: therapy with surgery, chemotherapy or a combination of the two?].

Authors:  R Ammann
Journal:  Langenbecks Arch Chir       Date:  1992

2.  An improved method for the extraction and quantification of adult Echinococcus from wildlife definitive hosts.

Authors:  Karen Gesy; Michael Pawlik; Luciene Kapronczai; Brent Wagner; Brett Elkin; Helen Schwantje; Emily Jenkins
Journal:  Parasitol Res       Date:  2013-03-08       Impact factor: 2.289

3.  Management of Advanced Hepatic Alveolar Echinococcosis: Report of 42 Cases.

Authors:  Bo Qu; Long Guo; Guannan Sheng; Fei Yu; Guannan Chen; Yupeng Wang; Yuan Shi; Hanxiang Zhan; Yi Yang; Xiaoyan Du
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 4.  Diagnosis and treatment of human hydatidosis.

Authors:  H Wen; R R New; P S Craig
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

5.  Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

6.  Alveolar echinococcosis of the liver: percutaneous stent therapy in Budd-Chiari syndrome.

Authors:  J Vogel; J Görich; E Kramme; E Merkle; R Sokiranski; P Kern; H J Brambs
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

7.  Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch; F R Wilson
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

8.  Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen.

Authors:  B Gottstein; P Jacquier; S Bresson-Hadni; J Eckert
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

Review 9.  [Liver transplantation and pregnancy: 1994 perspectives].

Authors:  P Sauthier; P Hohlfeld; F Mosimann; H Bossart
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

10.  Indications and results of liver transplantation for Echinococcus alveolar infection: an overview.

Authors:  Solange Bresson-Hadni; Stéphane Koch; Jean-Philippe Miguet; Michel Gillet; Georges-André Mantion; Bruno Heyd; Dominique-Angèle Vuitton
Journal:  Langenbecks Arch Surg       Date:  2003-08-05       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.